Clinical Trials and Pilots
 Studies, Decision Support and Informatics

Home | AboutProductsSolutionsTrials | Partners | NewsContact
Google Search
The Web

Remote-HF-1 Clinical Trial

Chronic conditions and long term illness accounts for a large percentage of patient visits to emergency rooms, hospital visits, re-hospitalizations and subsequent death in hospitals. 28.1 per cent of Medicare beneficiaries classified as chronically ill in the United States died in hospitals in 2007*. Several chronic conditions such as Congestive Heart Failure, Diabetes Mellitus, COPD, Pain amongst others can be controlled and prevented with practical technology innovation that can assist in many ways coupled with patient participation to prevent avoidable patient hospital visits and improve patient outcomes. Heart failure is an epidemic in the US with 5.7 Million Americans affected with Congestive Heart Failure in 1991. Of which, 670,000 new cases of CHF were being diagnosed per year with a morbidity rate estimated at 870,000 hospitalizations and 200,000 patient deaths per year. CHF costs today account for 10% of all hospital admissions with an annual U.S. Cost exceeding $50 billion.

Aventyn is conducting a multi-center, clinical study using Vitalbeat an easy to use mobile health application with its integrated chronic disease management system for at risk congestive heart failure patients at multiple hospitals across three continents. Details of the study and the protocol will be made available during the course of the study and its completion at the FDA PRS web site and the links attached here - Link to Remote-HF-1 Clinical Trial

Pharmaceutical companies, Medical Device manufacturers and Wireless Operators can contact Aventyn at to inquire how we can help with medication adherence, compliance and therapies; integrate new devices for disease management and include diverse patient demography with global mobile reach.   

*Source: Dartmouth Institute for Health Policy and Clinical Practice

Home | AboutProductsSolutionsTrials | Partners | NewsContact     Copyrightę 2004-2012 Aventyn, Inc. All Rights Reserved